Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to 0.09.

  • Sanara MedTech's Equity Ratio fell 8074.87% to 0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09, marking a year-over-year decrease of 8074.87%. This contributed to the annual value of 0.45 for FY2024, which is 2589.36% down from last year.
  • According to the latest figures from Q3 2025, Sanara MedTech's Equity Ratio is 0.09, which was down 8074.87% from 0.36 recorded in Q2 2025.
  • Sanara MedTech's 5-year Equity Ratio high stood at 0.92 for Q1 2021, and its period low was 0.09 during Q3 2025.
  • Over the past 5 years, Sanara MedTech's median Equity Ratio value was 0.61 (recorded in 2024), while the average stood at 0.63.
  • Its Equity Ratio has fluctuated over the past 5 years, first surged by 6271.6% in 2021, then tumbled by 8074.87% in 2025.
  • Quarter analysis of 5 years shows Sanara MedTech's Equity Ratio stood at 0.84 in 2021, then fell by 18.81% to 0.68 in 2022, then fell by 11.7% to 0.6 in 2023, then decreased by 25.89% to 0.45 in 2024, then crashed by 80.66% to 0.09 in 2025.
  • Its Equity Ratio stands at 0.09 for Q3 2025, versus 0.36 for Q2 2025 and 0.38 for Q1 2025.